These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 8867947)

  • 21. High-cholesterol diets impair short-term retention of memory in alloxan-induced diabetic mice, but not acquisition of memory nor retention of memory in prediabetic mice.
    Xie W; Du L
    Life Sci; 2005 Jun; 77(5):481-95. PubMed ID: 15904667
    [TBL] [Abstract][Full Text] [Related]  

  • 22. New drugs for the treatment of hypercholesterolemia.
    Hamlin JT
    Va Med Mon (1918); 1969 Jan; 96(1):11-2. PubMed ID: 5763103
    [No Abstract]   [Full Text] [Related]  

  • 23. Use and indications of cholestyramine and bile acid sequestrants.
    Scaldaferri F; Pizzoferrato M; Ponziani FR; Gasbarrini G; Gasbarrini A
    Intern Emerg Med; 2013 Apr; 8(3):205-10. PubMed ID: 21739227
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diabetes, statins and cardiovascular disease.
    Jackson G
    Int J Clin Pract; 2001 Jun; 55(5):291. PubMed ID: 11452674
    [No Abstract]   [Full Text] [Related]  

  • 25. Essential hyperlipemia with xanthomatosis: effects of cholestyramine and clofibrate.
    Roe DA
    Arch Dermatol; 1968 Apr; 97(4):436-45. PubMed ID: 5643239
    [No Abstract]   [Full Text] [Related]  

  • 26. [Dual cholesterol inhibition. More high risk patients achieve LDL cholesterol values below 100 mg/dl].
    MMW Fortschr Med; 2008 Jun; 150(23):39. PubMed ID: 18575369
    [No Abstract]   [Full Text] [Related]  

  • 27. [The Prosper-Study: practical consequences?].
    Traut V
    Internist (Berl); 2004 May; 45(5):614-6. PubMed ID: 15181887
    [No Abstract]   [Full Text] [Related]  

  • 28. The cause of atherosclerosis.
    Roberts WC
    Nutr Clin Pract; 2008; 23(5):464-7. PubMed ID: 18849550
    [No Abstract]   [Full Text] [Related]  

  • 29. Regulation of hepatic cholesterol metabolism in CETP/LDLr mice by cholesterol feeding and by drugs (cholestyramine and lovastatin) that lower plasma cholesterol.
    Harada LM; Carrilho AJ; Oliveira HC; Nakandakare ER; Quintão EC
    Clin Exp Pharmacol Physiol; 2006 Dec; 33(12):1209-15. PubMed ID: 17184503
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serum cholesterol and cholelithias in rabbits treated with pectin and cholestyramine.
    Borgman RF; Wardlaw FB
    Am J Vet Res; 1974 Nov; 35(11):1445-7. PubMed ID: 4429245
    [No Abstract]   [Full Text] [Related]  

  • 31. The effect of cholesterol-lowering treatment on renal function.
    Liberopoulos EN; Mikhailidis DP; Athyros VG; Elisaf MS
    Am J Kidney Dis; 2006 Mar; 47(3):561; author reply 562. PubMed ID: 16490637
    [No Abstract]   [Full Text] [Related]  

  • 32. Ramipril improves oxidative stress-related vascular endothelial dysfunction in db/db mice.
    Liang W; Tan CY; Ang L; Sallam N; Granville DJ; Wright JM; Laher I
    J Physiol Sci; 2008 Dec; 58(6):405-11. PubMed ID: 18845058
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effectiveness and tolerability of ezetimibe add-on therapy to a bile acid resin-based regimen for hypercholesterolemia.
    Xydakis AM; Guyton JR; Chiou P; Stein JL; Jones PH; Ballantyne CM
    Am J Cardiol; 2004 Sep; 94(6):795-7. PubMed ID: 15374793
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mechanisms underlying the chronic pravastatin treatment-induced improvement in the impaired endothelium-dependent aortic relaxation seen in streptozotocin-induced diabetic rats.
    Kobayashi T; Matsumoto T; Kamata K
    Br J Pharmacol; 2000 Sep; 131(2):231-8. PubMed ID: 10991915
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Regulation of fecal bile acid excretion in male golden Syrian hamsters fed a cereal-based diet with and without added cholesterol.
    Turley SD; Spady DK; Dietschy JM
    Hepatology; 1997 Apr; 25(4):797-803. PubMed ID: 9096579
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fluvastatin in combination with other lipid-lowering agents.
    Jokubaitis LA
    Br J Clin Pract Suppl; 1994 Dec; (77):28-32. PubMed ID: 19496270
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparative effects of simvastatin and cholestyramine on plasma lipoproteins and CETP in humans.
    McPherson R
    Can J Clin Pharmacol; 1999; 6(2):85-90. PubMed ID: 10519734
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Pravastatin multicenter clinical trial in patients with hypercholesterolemia and multiple risk factors].
    Barrett e Pesquisadores AC
    Arq Bras Cardiol; 1997 Jan; 68(1):65-71. PubMed ID: 9334463
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A need to redefine the consensus on the use of statins in coronary heart disease prevention.
    Fruchart JC
    Eur Heart J; 2000 Oct; 21(19):1572-3. PubMed ID: 10988008
    [No Abstract]   [Full Text] [Related]  

  • 40. [Intensive LDL lowering to under 80 mg/dl: hypercholesteremia patients with stable coronary disease and diabetes profit especially significantly].
    MMW Fortschr Med; 2005 Aug; 147(33-34):50-1. PubMed ID: 16138640
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.